Adelaide research team claims to have successfully memgembangkan vaccine to prevent skin cancer or melanoma . Disease that kills about 1,500 Australians each year
Over the past 14 years, a cancer expert at the University of Adelaide , Brendon Coventry and Melanoma Foundation of Australia has developed a melanoma or skin cancer vaccine .
The trial involved 54 patients with secondary melanoma cases . The patient is given an injection of the vaccine in several stages . At the beginning of therapy the patient is given an injection of the vaccine every two weeks , and then given an injection every month and end up only twice a year .
Dr. . Coventry said the key to the development of a vaccine that is by giving repeated doses of the vaccine and in the long run .
" From the test results so far shown that this vaccine can successfully modulate or modify the cancer patient’s immune system to produce long-term survival by removing the tumor in the body as a whole , about 17 percent of cases , " he said recently.
" This is one of the few studies that were able to get above 15 % success to eliminate cases of advanced melanoma , " he said proudly .
" Many other studies that use highly complex regimen once highly toxic regimens . Whilst this vaccine regimen contains very little and has no side effects at all , though perhaps aka tone reddish spots but there were no reports of side effects of other complaints , "
Dr. . Coventry said these trials help researchers understand how the patient’s immune system can be manipulated to fight cancer .
He said the next step is to see what happens to the immune system after the vaccine is given .
" The immune system works in a way that seems like mechanism On - Off continuously and now what we are trying to do is we want to see if we can identify periods or phases in the cycle ON - Off where we can target the vaccine could be more effective and might even be able to give a response above 17 percent , " he said .
Dr Coventry said the success of the trial vaksini ni can be used as a basis for treating other cancers .
Meanwhile Barry Foote aged 50 years , melanoma is one of the cancer patients were included in this vaccine trial admitted after getting the vaccine lot number of tumors in the skin is reduced .
" I was a little worried initially , but then I realized that the number of tumors in my body started to disappear and I am very happy , " said Foote .
Foote was 50 years old when diagnosed with an aggressive melanoma and is expected to survive only a year ago .
" The doctor said I might not survive another 12 months , but 14 years later I am still alive , " he said .
Burning sensation becomes complained for getting the kindling .
" Dr . Coventry say if this vaccine works then I will feel a little pain section tumor growth and indeed I feel it but I am quite happy because I know that the vaccine is working . " He said .
( Read: anis merah mp3 )
In Australia reported there were 12 thousand new cases of melanoma each year . Recent research results have been published in the Journal of Cancer for immunotherapy .